Quantcast
Channel: London and Watford based solicitors | Matthew Arnold & Baldwin » M&A
Viewing all articles
Browse latest Browse all 5

Shire hostile US$30bn bid for Baxalta aims to establish world’s largest rare disease medicine supplier

0
0
The deal activity in the pharma world continues apace, as the question remains: who is going to bid for whom next? Shire has put in a hostile US$30bn bid for fellow rare disease medicine supplier, Baxalta. Just nine months previously, Shire was itself nearly sold to Abbvie, before the deal collapsed. Baxalta specialises in haemophilia,… Learn more

Viewing all articles
Browse latest Browse all 5

Latest Images

Trending Articles





Latest Images